BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 35858628)

  • 1. Bi-allelic variants in DOHH, catalyzing the last step of hypusine biosynthesis, are associated with a neurodevelopmental disorder.
    Ziegler A; Steindl K; Hanner AS; Kar RK; Prouteau C; Boland A; Deleuze JF; Coubes C; Bézieau S; Küry S; Maystadt I; Le Mao M; Lenaers G; Navet B; Faivre L; Tran Mau-Them F; Zanoni P; Chung WK; Rauch A; Bonneau D; Park MH
    Am J Hum Genet; 2022 Aug; 109(8):1549-1558. PubMed ID: 35858628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recessive Rare Variants in Deoxyhypusine Synthase, an Enzyme Involved in the Synthesis of Hypusine, Are Associated with a Neurodevelopmental Disorder.
    Ganapathi M; Padgett LR; Yamada K; Devinsky O; Willaert R; Person R; Au PB; Tagoe J; McDonald M; Karlowicz D; Wolf B; Lee J; Shen Y; Okur V; Deng L; LeDuc CA; Wang J; Hanner A; Mirmira RG; Park MH; Mastracci TL; Chung WK
    Am J Hum Genet; 2019 Feb; 104(2):287-298. PubMed ID: 30661771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-translational formation of hypusine in eIF5A: implications in human neurodevelopment.
    Park MH; Kar RK; Banka S; Ziegler A; Chung WK
    Amino Acids; 2022 Apr; 54(4):485-499. PubMed ID: 34273022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuron-specific ablation of eIF5A or deoxyhypusine synthase leads to impairments in growth, viability, neurodevelopment, and cognitive functions in mice.
    Kar RK; Hanner AS; Starost MF; Springer D; Mastracci TL; Mirmira RG; Park MH
    J Biol Chem; 2021 Nov; 297(5):101333. PubMed ID: 34688659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular cloning, expression, and structural prediction of deoxyhypusine hydroxylase: a HEAT-repeat-containing metalloenzyme.
    Park JH; Aravind L; Wolff EC; Kaevel J; Kim YS; Park MH
    Proc Natl Acad Sci U S A; 2006 Jan; 103(1):51-6. PubMed ID: 16371467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity of the deoxyhypusine hydroxylase-eukaryotic translation initiation factor (eIF5A) interaction: identification of amino acid residues of the enzyme required for binding of its substrate, deoxyhypusine-containing eIF5A.
    Kang KR; Kim YS; Wolff EC; Park MH
    J Biol Chem; 2007 Mar; 282(11):8300-8. PubMed ID: 17213197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypusine, a polyamine-derived amino acid critical for eukaryotic translation.
    Park MH; Wolff EC
    J Biol Chem; 2018 Nov; 293(48):18710-18718. PubMed ID: 30257869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of active recombinant eIF5A: reconstitution in E.coli of eukaryotic hypusine modification of eIF5A by its coexpression with modifying enzymes.
    Park JH; Dias CA; Lee SB; Valentini SR; Sokabe M; Fraser CS; Park MH
    Protein Eng Des Sel; 2011 Mar; 24(3):301-9. PubMed ID: 21131325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A unique modification of the eukaryotic initiation factor 5A shows the presence of the complete hypusine pathway in Leishmania donovani.
    Chawla B; Kumar RR; Tyagi N; Subramanian G; Srinivasan N; Park MH; Madhubala R
    PLoS One; 2012; 7(3):e33138. PubMed ID: 22438895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential role of eIF5A-1 and deoxyhypusine synthase in mouse embryonic development.
    Nishimura K; Lee SB; Park JH; Park MH
    Amino Acids; 2012 Feb; 42(2-3):703-10. PubMed ID: 21850436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The post-translational synthesis of a polyamine-derived amino acid, hypusine, in the eukaryotic translation initiation factor 5A (eIF5A).
    Park MH
    J Biochem; 2006 Feb; 139(2):161-9. PubMed ID: 16452303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional significance of eIF5A and its hypusine modification in eukaryotes.
    Park MH; Nishimura K; Zanelli CF; Valentini SR
    Amino Acids; 2010 Feb; 38(2):491-500. PubMed ID: 19997760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posttranslational synthesis of hypusine: evolutionary progression and specificity of the hypusine modification.
    Wolff EC; Kang KR; Kim YS; Park MH
    Amino Acids; 2007 Aug; 33(2):341-50. PubMed ID: 17476569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the polyamine-hypusine circuit for the prevention and treatment of cancer.
    Nakanishi S; Cleveland JL
    Amino Acids; 2016 Oct; 48(10):2353-62. PubMed ID: 27357307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assay of deoxyhypusine hydroxylase activity.
    Park JH; Wolff EC; Park MH
    Methods Mol Biol; 2011; 720():207-16. PubMed ID: 21318876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deoxyhypusine synthase mutations alter the post-translational modification of eukaryotic initiation factor 5A resulting in impaired human and mouse neural homeostasis.
    Padgett LR; Shinkle MR; Rosario S; Stewart TM; Foley JR; Casero RA; Park MH; Chung WK; Mastracci TL
    HGG Adv; 2023 Jul; 4(3):100206. PubMed ID: 37333770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic drug combination GC7/DFMO suppresses hypusine/spermidine-dependent eIF5A activation and induces apoptotic cell death in neuroblastoma.
    Schultz CR; Geerts D; Mooney M; El-Khawaja R; Koster J; Bachmann AS
    Biochem J; 2018 Jan; 475(2):531-545. PubMed ID: 29295892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting deoxyhypusine hydroxylase activity impairs cap-independent translation initiation driven by the 5'untranslated region of the HIV-1, HTLV-1, and MMTV mRNAs.
    Cáceres CJ; Angulo J; Contreras N; Pino K; Vera-Otarola J; López-Lastra M
    Antiviral Res; 2016 Oct; 134():192-206. PubMed ID: 27633452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of HIV-1 gene expression by Ciclopirox and Deferiprone, drugs that prevent hypusination of eukaryotic initiation factor 5A.
    Hoque M; Hanauske-Abel HM; Palumbo P; Saxena D; D'Alliessi Gandolfi D; Park MH; Pe'ery T; Mathews MB
    Retrovirology; 2009 Oct; 6():90. PubMed ID: 19825182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of EIF5A hypusination limits colorectal cancer growth by inhibiting MYC elongation.
    Coni S; Serrao SM; Yurtsever ZN; Di Magno L; Bordone R; Bertani C; Licursi V; Ianniello Z; Infante P; Moretti M; Petroni M; Guerrieri F; Fatica A; Macone A; De Smaele E; Di Marcotullio L; Giannini G; Maroder M; Agostinelli E; Canettieri G
    Cell Death Dis; 2020 Dec; 11(12):1045. PubMed ID: 33303756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.